View the trials we are currently recruiting for below and if you are interested please sign up to see if you may qualify. If you qualify, someone from the study research center (where the clinical trial takes place) will contact you with more information.
If there are any other conditions you are interested in participating in, please submit your information into our database at the bottom of this page. We will contact you as soon as we have a study for your condition within your area!
AutoCruitment’s in house design and medical copywriting team develops creative, branded and customized materials targeting the ideal candidates for your study. With the ability to go live within one business day of IRB approval.
AutoCruitment’s propriety technology platform uses online browser behavior and geotargeting to target interested and qualified patients while they are online searching for information on their condition via the AutoCruitment Search, Display, Social Media and Partner Mobile Channels.
The AutoCruitment Platform pre-qualifies patients using sophisticated online screeners based on I/E criteria. Once qualified, patients are referred to research sites in real time via the AutoCruitment Portal, with the option to utilize AutoCruitment’s Medically staffed Patient Engagement Team.
Each research site receives access to a personalized and secure AutoCruitment portal allowing for user-friendly patient management as qualified patients are referred in real-time. Ensuring a seamless integration.
The AutoCruitment Portal ensures real-time tracking of qualified patients as they move through the recruitment funnel. With custom reporting made available via the AutoCruitment Portal Dashboard, allowing transparency and visibility for Sponsor and CRO Clients.
The AutoCruitment Project Management and Site Engagement Team work holistically in collaboration with the Study Team and Research Sites to continually adapt and optimize the program, with a focus on Randomization.
AutoCruitment’s patient recruitment platform supports Sponsors, CRO Partners and Research Sites by decreasing time, risk and cost to bring new therapies to market.